Tricuspid regurgitation stages: Difference between revisions
Rim Halaby (talk | contribs) No edit summary |
Rim Halaby (talk | contribs) (→Stages) |
||
Line 9: | Line 9: | ||
Shown below is a table depicting the stages of TR adapted from the 2014 AHA/ACC guidelines for management of valvular heart disease.<ref name="pmid24589852">{{cite journal| author=Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP, Guyton RA et al.| title=2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. | journal=Circulation | year= 2014 | volume= | issue= | pages= | pmid=24589852 | doi=10.1161/CIR.0000000000000029 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=24589852 }} </ref> | Shown below is a table depicting the stages of TR adapted from the 2014 AHA/ACC guidelines for management of valvular heart disease.<ref name="pmid24589852">{{cite journal| author=Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP, Guyton RA et al.| title=2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. | journal=Circulation | year= 2014 | volume= | issue= | pages= | pmid=24589852 | doi=10.1161/CIR.0000000000000029 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=24589852 }} </ref> | ||
<span style="font-size:85%">'''Abbreviations:''' '''CW:''' continuous wave; '''ICD:''' implantable cardioverter-defibrillator; '''IE:''' infective endocarditis; '''IVC:''' inferior vena cava; '''RA:''' right atrium; '''RV:''' right ventricle; '''TR:''' tricuspid regurgitation</span> | <span style="font-size:85%">'''Abbreviations:''' '''CW:''' continuous wave; '''ICD:''' [[implantable cardioverter-defibrillator]]; '''IE:''' [[infective endocarditis]]; '''IVC:''' [[inferior vena cava]]; '''RA:''' [[right atrium]]; '''RV:''' [[right ventricle]]; '''TR:''' [[tricuspid regurgitation]]</span> | ||
{|Class="wikitable" | {|Class="wikitable" | ||
Line 85: | Line 85: | ||
* Increased RA pressure with “c-V” wave | * Increased RA pressure with “c-V” wave | ||
* Possible diastolic interventricular septal flattening | * Possible diastolic interventricular septal flattening | ||
| Presence of symptoms ([[ | | Presence of symptoms ([[fatigue]], [[dyspnea]], [[anorexia]], [[edema]], [[abdominal distention]], [[palpitations]]) | ||
|- | |- | ||
|} | |} |
Revision as of 14:09, 12 September 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Rim Halaby, M.D. [2]
Tricuspid Regurgitation Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Tricuspid regurgitation stages On the Web |
American Roentgen Ray Society Images of Tricuspid regurgitation stages |
Risk calculators and risk factors for Tricuspid regurgitation stages |
Overview
The stage of tricuspid regurgitation (TR) can be estimated based on specific criteria for the valve anatomy, valve hemodynamics, associated cardiac findings, and symptoms. The stages of TR are the following: at risk of TR, progressive TR, asymptomatic severe TR, and symptomatic severe TR.[1]
Stages
Shown below is a table depicting the stages of TR adapted from the 2014 AHA/ACC guidelines for management of valvular heart disease.[1]
Abbreviations: CW: continuous wave; ICD: implantable cardioverter-defibrillator; IE: infective endocarditis; IVC: inferior vena cava; RA: right atrium; RV: right ventricle; TR: tricuspid regurgitation
Stage | Definition | Valve anatomy | Valve hemodynamics | Hemodynamic consequences | Symptoms |
---|---|---|---|---|---|
A | At risk of TR | Primary
Secondary
|
Absent | Absent | Absent |
B | Progressive TR | Primary
Secondary
|
Mild TR
Moderate TR
|
Mild TR
Moderate TR |
Absent |
C | Asymptomatic severe TR | Primary
Secondary
|
* Central jet area >10.0 cm2
|
* Dilated RV/RA/IVC and decreased IVC respirophasic variation
|
Absent |
D | Symptomatic severe TR | Primary
Secondary
|
* Central jet area >10.0 cm2
|
* Dilated RV/RA/IVC and decreased IVC respirophasic variation
|
Presence of symptoms (fatigue, dyspnea, anorexia, edema, abdominal distention, palpitations) |
References
- ↑ 1.0 1.1 Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP, Guyton RA; et al. (2014). "2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines". Circulation. doi:10.1161/CIR.0000000000000029. PMID 24589852.